Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the subchronic gastrointestinal (GI) safety of PL3100 versus Naproxen in normal healthy volunteers.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
PLx Pharma
Collaborators
NCT07069218 · Enamel Hypomineralization, Tooth Erosion
NCT07442136 · Enamel Erosion
NCT06513936 · Medical Device Site Erosion
NCT07461103 · Pemphigus Vulgaris, Skin Erosion, and more
NCT04208802 · Dental Erosion
Dallas VA Medical Center
Dallas, Texas
Houston Center For Clinical Research
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions